Skip to main content
. 2019 Feb;64:28–36. doi: 10.1016/j.medengphy.2018.12.011

Fig. 6.

Fig. 6

Transaxial dose distributions for (a) prostate A, (b) prostate B, (c) lung, (d) liver and (e) partial breast cases. The dose levels as a percentage of the prescription dose are shown in each case.